Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-19T09:37:56.076Z Has data issue: false hasContentIssue false
  • English
  • Français

Investigating the role of vitamin A in melatonin production in the pineal gland

Published online by Cambridge University Press:  03 June 2015

A. J. Ashton ,
P. N. Stoney  and
P. J. McCaffery
A. J. Ashton
Affiliation:
Institute of Medical Sciences, School of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK
P. N. Stoney
Affiliation:
Institute of Medical Sciences, School of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK
P. J. McCaffery
Affiliation:
Institute of Medical Sciences, School of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, AB25 2ZD, Scotland, UK
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 74 , Issue OCE3: Scottish Section Meeting, 25–26 March 2015, Diet, gene regulation and metabolic disease , 2015 , E195
Copyright
Copyright © The Authors 2015 

The pineal gland is situated at the midline of the brain and produces melatonin, the hormone responsible for signalling darkness to the body and entraining daily physiological rhythms. The nightly production of melatonin is induced by upregulation of arylalkylamine N-acetyltransferase (AANAT) gene expression and activity, the rate-limiting enzyme for melatonin synthesis. A reduction in melatonin is associated with metabolic dysfunction, increased body weight and type 2 diabetes( Reference Chen, Tiong and Tsai 1 , Reference Korkmaz, Topal and Tan 2 ), it is therefore important to understand how melatonin synthesis is regulated. Studies have shown there are high levels of retinol (vitamin A) and retinol binding proteins in the mammalian pineal gland( Reference Phillips, Tsin and Reiter 3 , Reference Smeland, Bjerknes and Malaba 4 ) and that vitamin A deficiency causes a reduction in AANAT and melatonin levels( Reference Guillaumond, Giraudet and Becquet 5 , Reference Herbert and Reiter 6 ). The effects of retinol are thought to be mediated by the active metabolite retinoic acid (RA), a potent regulator of gene transcription. This study aims to confirm whether RA signalling components are present in the pineal gland and determine whether RA can regulate melatonin production.

Male Sprague Dawley rat pineal glands were collected at six hour intervals throughout the light/dark cycle and analysed by qPCR to identify RA signalling components and determine whether they exhibit a circadian rhythm in expression (n ⩾ 7 pineal glands per timepoint). Organotypic culture of ex vivo rat pineal glands and qPCR analysis were then used to study the effect of RA on Aanat gene expression. Pineal glands were treated for four hours with RA alone, RA with cyclic AMP (the physiological mediator of Aanat upregulation), cyclic AMP alone or vehicle control (n ⩾ 5).

RA receptors and key synthetic enzymes were found in the rodent pineal gland, some of which exhibit diurnal (day/night) changes in expression. Expression of the RA synthetic enzyme retinol dehydrogenase 10 (Rdh10) and the RA receptor subtype gamma (Rarg) increased at night compared to day (P < 0·05 and P < 0·01, respectively), suggesting rhythms in RA signalling in this gland. Treatment of cultured pineal glands with RA and cyclic AMP was found to significantly increase Aanat expression compared to cyclic AMP alone (P < 0·01). Aanat expression in pineal glands treated with RA alone and vehicle control was comparable. The results demonstrate that the components required for RA signalling are present in the pineal gland and suggest that RA has a role in the regulation of melatonin synthesis.

References

1. Chen, L, Tiong, C, Tsai, C et al. (2014) Brain Struct Funct DOI. 10.1007/s00429-014-0716-x.Google Scholar
2. Korkmaz, A, Topal, T, Tan, D et al. (2009) Rev Endocr Metab Disord 10, 261–270.Google Scholar
3. Phillips, TS, Tsin, AT, Reiter, RJ et al. (1989) Brain Res Bull. 22, 259–61.Google Scholar
4. Smeland, S, Bjerknes, T, Malaba, L et al. (1995) Biochem J. 305, 419–24.Google Scholar
5. Guillaumond, F, Giraudet, F, Becquet, D et al. (2005) Eur J Neurosci. 21, 798–802.Google Scholar
6. Herbert, DC & Reiter, RJ (1985) Life Sci. 37, 2515–22.CrossRefGoogle Scholar